Clinical Outcomes at 2 Years Between Beta-Blockade with ACE Inhibitors or ARBs in Patients with AMI Who Underwent Successful PCI with DES: A Retrospective Analysis of 23,978 Patients in the Korea AMI Registry.

MLA

Kim, Yong Hoon, et al. “Clinical Outcomes at 2 Years Between Beta-Blockade with ACE Inhibitors or ARBs in Patients with AMI Who Underwent Successful PCI with DES: A Retrospective Analysis of 23,978 Patients in the Korea AMI Registry.” American Journal of Cardiovascular Drugs, vol. 19, no. 4, Aug. 2019, pp. 403–14. EBSCOhost, https://doi.org/10.1007/s40256-019-00326-8.

APA

Kim, Y. H., Her, A.-Y., Jeong, M. H., Kim, B.-K., Hong, S.-J., Shin, D.-H., Kim, J.-S., Ko, Y.-G., Choi, D., Hong, M.-K., & Jang, Y. (2019). Clinical Outcomes at 2 Years Between Beta-Blockade with ACE Inhibitors or ARBs in Patients with AMI Who Underwent Successful PCI with DES: A Retrospective Analysis of 23,978 Patients in the Korea AMI Registry. American Journal of Cardiovascular Drugs, 19(4), 403–414. https://doi.org/10.1007/s40256-019-00326-8

Chicago

Kim, Yong Hoon, Ae-Young Her, Myung Ho Jeong, Byeong-Keuk Kim, Sung-Jin Hong, Dong-Ho Shin, Jung-Sun Kim, et al. 2019. “Clinical Outcomes at 2 Years Between Beta-Blockade with ACE Inhibitors or ARBs in Patients with AMI Who Underwent Successful PCI with DES: A Retrospective Analysis of 23,978 Patients in the Korea AMI Registry.” American Journal of Cardiovascular Drugs 19 (4): 403–14. doi:10.1007/s40256-019-00326-8.